As communities across the country reopened, the SARS-CoV-2 (also known as COVID-19) public health emergency shifted from an acute phase into a chronic phase. ACCC resources from the pandemic's acute phase can be found here.
An expert panel of past ACCC Presidents will share their perspectives on changes to clinical research during the pandemic.
COVID-19 has impacted how providers are dispensing multiple myeloma medications and providing care to patients during the pandemic. Learn how to identify those effects to help mitigate them and implement strategies to improve telehealth medicine during the pandemic.
Join Charles Saunders, MD, Chief Executive Officer, and Jennifer Webster, MS, Vice President of Analytics, IntegraConnect, as they present an overview of the current landscape of patient levels and services at cancer programs. (July 10, 2020)
Teri Bedard, BA, RT(R)(T), CPC, Executive Director, Client & Corporate Resources, Revenue Cycle Coding Strategies, highlights what your cancer program needs to know by discussing the changes to telehealth services, supervision, provider-based designations, and coding for services. (July 10, 2020)
Join Raju K. Vaddepally, MD, Yuma Regional Medical Center Cancer Center, to discuss strategies for sustaining a robust clinical trials program in uncertain times and how to increase the relevance of research to vulnerable and underserved patients. (June 26, 2020)
See what members are discussing in the COVID-19 Forum, exclusively for ACCC Members. (Requires Login)
ACCC launched a COVID-19 Resource Center in March 2020 to offer education and tools to community practitioners working directly on the frontlines.
Envision a day that cancer clinicians can ask an app to advise on immuno-oncology (IO) treatment options for a patient. That day may not be far off.
SARS-CoV-2 and the resulting respiratory tract infection COVID-19 has upended our society and forcefully changed the way we care for patients. Since the emergence of the virus in early 2020, there have been questions surrounding the risk posed to patients with a cancer diagnosis and the safety of anticancer therapies.
COVID-19 information, resources, and toolkits are organized by category below. Click on the category to access quick links.
Academy of Oncology Nurse & Patient Navigators
AONN+ COVID-19 Navigator Toolkit
This toolkit provides invaluable resources to assist nurse navigators and patient navigators in the management of patient care during the coronavirus pandemic.
American College of Surgeons
The American College of Surgeons COVID-19 and Surgery online resource.
ACS accreditation and verification programs grant one year extension (includes Commission on Cancer). (3/24/2020)
ACS Cancer Programs Site Visit Postponement FAQs (updated 5/1/2020)
Joint Statement: Roadmap for Resuming Elective Surgery after COVID-19 Pandemic by the American College of Surgeons, American Society of Anesthesiologists, Association of periOperative Registered Nurses, and the American Hospital Association
ACS COVID-19 Registry
American Medical Association (AMA)
AMA COVID-19 resource center for physicians, includes:
American Pharmacists Association (APhA)
Pharmacists' Guide to Coronavirus. Information and resources for pharmacists and the communities they serve.
Know the Facts: Telehealth in Your Pharmacy Practice
National Alliance of State Pharmacy Associations COVID-19 information from states.
American Society of Clinical Oncology (ASCO)
Survey on COVID-19 in Oncology Registry (ASCO Registry) find links to survey study scheme, FAQs, and IRB exemption letter.
ASCO COVID-19 Resources
ASCO Guide to Cancer Care Delivery During COVID-19 (May 19, 2020)
American Society of Hematology (ASH)
COVID-19 Resources for Hematologists (last updated June 9, 2020)
ASH Research Collaborative COVID-19 Registry for Hematologic Malignancy
American Society of Health-System Pharmacists (AHSP)
ASHP COVID-19 Resource Center
ASHP open access to resources during COVID-19
ASHP Patient Surge Management During a Pandemic: Toolkit for Hospital and Health System Pharmacy (June 2020)
American Society for Radiation Oncology (ASTRO)
ASTRO National Survey of COVID-19 Impact on Radiation Oncology Practices: Initial findings (5/20/20)
COVID-19 Information for Radiation Oncology Practices
COVID-19 Summary of Information and Recommendations
Infectious Diseases Society of America (IDSA)
IDSA COVID-19 Resource Center
IDSA Guidelines on the Diagnosis of COVID-19 (published 5/6/2020)
IDSA COVID-19 Guideline, Part 1: Treatment and Management
IDSA COVID-19 Guideline, Part 2: Infection Prevention
IDSA COVID-19 Guideline, Part 3: Diagnostics
Lung Screening During COVID-19
A 24-member expert panel developed a consensus statement that covers lung cancer screening and monitoring, evaluation, management of lung nodules,"Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report." The report was published simultaneously in CHEST, Radiology: Imaging Cancer, and the Journal of the American College of Radiology. Full text is available here.
National Academies of Sciences, Engineering, and Medicine (NASEM)
Coronavirus Disease 2019 (COVID-19) News and Resources.
National Academy of Medicine Resources for Clinician Health & Well-Being During COVID-19
National Comprehensive Cancer Network (NCCN)
Resources shared by NCCN members to help providers respond to coronavirus 2019.
COVID-19 response tools from Seattle Cancer Care Alliance.
Self-Care & Stress Management During COVID-19: Toolkit for Oncology HCPs
Oncology Nursing Society (ONS)
ONS information regarding COVID-19.
ASCO-ONS webinar series on Caring for People with Cancer During COVID-19 Pandemic
Society for the Immunotherapy of Cancer (SITC)
SITC COVID-19 Resources webpage
CDC COVID-19 website
Information for healthcare professionals (HCPs) on COVID-19
FAQs for healthcare professionals (updated June 4, 2020)
CMS “Current Emergencies” webpage includes summary and links to CMS COVID-19 actions and updates, such as waivers and flexibilities issued.
Quality Payment Program (QPP) COVID-19 Response Fact Sheet outlines multiple flexibilities QPP implemented by CMS in response to COVID-19.
Quality Reporting Requirements exceptions and extensions.
CMS COVID-19 Workforce Virtual Toolkit a curated set of online resources and tools to help state and local decision-makers managing healthcare workforce challenges in response to the COVID-19 emergency.
CMS Coronavirus Stakeholder Calls (recordings and transcripts)
FDA's Emergency Use Authorizations for diagnostic and therapeutic medical devices to diagnose and respond to public health emergencies is available here.
Medicaid Coverage & Payment
Expansion of Telehealth
On April 29, 2020, CMS announced additional sweeping changes to further expand telehealth coverage in response to the COVID-19 public health emergency. Learn more.
CMS has expanded telehealth coverage for Medicare beneficiaries under the 1135 waiver authority and the Coronavirus Preparedness and Response Supplemental Appropriations Act. Additionally, the HHS Office of Inspector General (OIG) is providing flexibility for healthcare providers to reduce or waive cost-sharing for telehealth visits paid by federal healthcare programs. Read CMS fact sheet. Read CMS Medicare Telehealth FAQs.
At-a-Glance Summary of FDA COVID-19 Response (last updated 6/4/20)
Food and Drug Administration (U.S. FDA) coronavirus 2019 website includes FAQs on shortage of PPE.
FDA clinical trials guidance for industry, investigators and institutional review boards conducting clinical trials during the coronavirus (COVID-19) pandemic.
FDA Policy for Certain REMS Requirements During COVID-19 Public Health Emergency for Industry and Health Care Professionals
Surgical Gown and Mask Conservation Strategies (letter to HCPs)
NIH COVID-19 Treatment Guidelines intended for healthcare professionals, the guidelines include therapeutics currently being used for COVID-19, assessing patients for risk and illness severity, treatment considerations for critical care patients.
Center to Advance Palliative Care (CAPC)
CAPC COVID-19 Response Resources
CAPC COVID-19 Virtual Office Hours Virtual Office Hours are small-group consulting calls with leading subject matter experts. Experienced faculty will answer your questions on a wide variety of challenging topics.
Johns Hopkins University & Medicine
JHU Coronavirus Resource Center
JHU Global COVID-19 Case Tracker map.
Adolescent and Young Adult Cancer Coalition COVID-19. A collaborative effort between patient advocacy organizations, patient experts, and healthcare professionals, CovidAYACancer.org shares COVID-19 related resources and information for AYA cancer patients, survivors and healthcare professionals who work with this patient population.
American Cancer Society (ACS)
Common Questions About the New Coronavirus Outbreak
Cancer Support Community (CSC)
What Cancer Patients and Survivors Need to Know About the Coronavirus.
Leukemia & Lymphoma Society (LLS)
Coronavirus Resources & What You Should Know
Helping Blood Cancer Patients Adjust to the New Normal by Gwen Nichols, MD, LLS Chief Medical Officer (3/2020)
COVID-19 and Lung Cancer (information available in English and Spanish)
COVID-19 FAQs for people with lung cancer
COVID-19 Conversations with Experts (videos)
National Coalition for Cancer Survivorship (NCCS)
NCCS/ASCO work together to answer commonly asked questions about COVID-19 for patients and survivors. Read Q & A here.
Patient Advocate Foundation (PAF)
PAF COVID Care Resource Center
Commonwealth Fund information on health coverage options for laid-off workers and others
Health insurers have made changes in response to the COVID-19 health emergency.
Find quick links to more details below.
Blue Cross Blue Shield (BCBS)
AstraZeneca COVID-19 information hub
Virtual recording studio for creating patient education in minutes COVID-19 Vidscrip Program
Bayer COVID-19 response information
Bristol Myers Squibb COVID-19 response information
Bristol Myers Squibb Expands Patient Support Program to Help Newly Uninsured Patients in the U.S. Read announcement.
Coherus Biosciences contact information
Eisai COVID-19 response message to patients and providers
Eisai COVID-19 response information
Eli Lilly and Company COVID-19 response information
Labcorp COVID-19 News and Guidance
Merck COVID-19 response information
Merck Broadens Patient Support and Patient Assistance Programs as Part of Overall COVID-19 Relief Efforts. Read announcement.
Pfizer COVID-19 response information
Regeneron Pharmaceuticals, Inc. COVID-19 response information
RxVantage COVID-19 resource library
TerSera COVID-19 Communication
TerSera Comunication COVID-19 Oncology Patient Assistance
Walgreens COVID-19 response information
Amid COVID-19 Vaccine Rollout, a Quarter of Health Care Workers Say They Won’t Get a Shot
January 25, 2021
Telehealth in the Wake of COVID-19
How COVID-19 is Threatening Cancer Care
May 19, 2020
Oncologists Scramble to Shift Resources, Develop New Protocols in Response to Novel Coronavirus
Apr 17, 2020
Cancer Clinical Research During the COVID-19 Pandemic
Apr 03, 2020
Advice from the front lines: How cancer centers can cope with COVID-19
April 2, 2020
ACCC Mobilizes to Support Delivery of Quality Cancer Care During COVID-19 Pandemic
Mar 27, 2020
Page last updated July 24, 2020